Immunologic characterization of chronic lymphocytic leukemia cells

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Chronic lymphocytic leukemia (CLL) is a lymphoid malignancy characterized by the accumulation of neoplastic lymphocytes.
• Understanding the immunologic profile of these cells is crucial for diagnosis and potential therapeutic strategies.

Purpose of the Study:

• To immunologically characterize the neoplastic cells in CLL patients.
• To compare the membrane characteristics of CLL cells with normal B lymphocytes.

Main Methods:

• Immunologic assays were performed on circulating neoplastic cells from CLL patients.
• Analysis included membrane-associated immunoglobulin, reactivity with anti-human T cell serum, complement receptor expression (mouse and guinea pig), surface immunoglobulin (SIg) and E-rosetting cell counts, and mitogenic responses.

Main Results:

• CLL cells displayed homogenous membrane-associated immunoglobulin but also reacted with anti-T cell serum (60-90% staining).
• Marked increase in mouse-complement receptors, but not guinea pig complement receptors, was observed in CLL cells compared to normal B cells.
• The population of SIg-bearing lymphocytes was greater than complement-receptor bearing lymphocytes, and E-rosetting cells were increased.
• Mitogenic responses of CLL cells were depressed and delayed.

Conclusions:

• Neoplastic lymphocytes in CLL exhibit distinct immunologic features that differ from normal B lymphocytes.
• CLL cells share antigenic determinants with T lymphocytes and show altered complement receptor expression.
• Current criteria for classifying lymphocytes as T- or B-derived may not adequately categorize neoplastic lymphocytes in CLL.